UnknownNCT05149495

Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery

Studying Acromegaly

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Strasbourg, France
Principal Investigator
Philippe BALTZINGER, MD, M.D
Service Médecine Interne, Endocrinologie et Nutrition - Hôpitaux Universitaires de Strasbourg
Enrollment
100 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05149495 on ClinicalTrials.gov

Other trials for Acromegaly

Additional recruiting or active studies for the same condition.

See all trials for Acromegaly →

← Back to all trials